当前位置:

网站首页>文章详情

瑞舒伐他汀对急性心肌梗死患者PCI术后炎症因子和血液流变学的影响

【PDF在线阅读】 【下载PDF】

摘要:

目的 探讨瑞舒伐他汀对急性心肌梗死患者经皮冠状动脉介入治疗(PCI)术后炎症因子和血液流变学的影响。方法 选择2014年8月~2016年8月新疆喀什地区第二人民医院收治的急性心肌梗死患者148例,其中男性83例,女性65例,年龄55~70岁,平均年龄(60.21±8.95)岁。将患者依据入院顺序随机分为对照组(75例)和观察组(73例)。两组患者入院后根据病情给予药物治疗以及行PCI,观察组在此基础上加服瑞舒伐他汀,PCI术后连续7 d口服。检测治疗前和治疗7 d后两组的血脂,包括三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)及高密度脂蛋白胆固醇(HDL-C),炎症因子包括白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)及高敏C反应蛋白(hs-CRP),及血液流变学相关指标,包括纤维蛋白原(FIB)、血沉(ESR)、血浆粘度(PV)、全血低切黏度(NBL)和全血高切黏度(NBH)。结果 两组治疗后较治疗前TG、TC、LDL-C及HDL-C均明显改善,其中观察组改善更明显,差异有统计学意义(P均<0.05)。与治疗前比较,两组治疗后IL-6、TNF-α及hs-CRP水平均降低,观察组降低更明显,差异有统计学意义(P均<0.05)。与治疗前比较,两组治疗后FIB、ESR、PV、NBL和NBH均下降,观察组较对照组下降更明显,差异有统计学意义(P均<0.05)。结论瑞舒伐他汀可明显改善急性心肌梗死患者PCI术后的血脂水平,同时可抑制炎症因子水平和改善血液流变学指标。

Abstract:

 Objective To explore the effect of resuvastatin on inflammatory factors and hemodynamics in
patients with acute myocardial infarction after PCI. Methods 148 patients with acute myocardial infarction enrolled
from August 2014 to August 2016 were randomly divided into control group (75 patients) and observation group (73
patients). The control group was given routine medication, the observation group was treated with resuvastatin on
the basis of the control group. The changes of TG, TC, LDL-C, HDL-C, IL-6, TNF-α, hs-CRP, FIB, ESR, PV,
NBL and NBH were detected before and after treatment. Result The levels of TG, TC, LDL-C and HDL-C before
and after treatment in both groups were significantly improved, the difference was statistically significant (all P
<0.05). Compared with those before treatment, the levels of IL-6, TNF-α and hs-CRP in both groups decreased
after treatment, the difference was statistically significant (all P<0.05). Compared with those before treatment, the
FIB, ESR, PV, NBL and NBH in both groups decreased after treatment, and were more decreased in the observation
group than those in the control group, the difference was statistically significant (all P<0.05). Conclusion
Resuvastatin can significantly improve the serum lipid level of patients with acute myocardial infarction after PCI
treatment, while inhibiting serum inflammatory factor level and hemodynamic indexes.

基金项目:

参考文献:

[1] Chung SC,Gedeborg R,Nicholas O,et al. Acute myocardial infarction:
a comparison of short-term survival in national outcome registries in
Sweden and the UK[J]. Lancet,2014, 383(9925):1305-12.
[2] 蒋科,余一知. 左西孟旦治疗急性心肌梗死后心力衰竭的临床效
果观察[J]. 湖南师范大学学报医学版,2016,13(3):114-6.
[3] Manchurov V,Ryazankina N,Khmara T,et al. Remote ischemic
preconditioning and endothelial function in patients with acute
myocardial infarction and primary PCI[J]. Am J Med,2014,
127(7):670-3.
[4] Cung TT,Morel O,Cayla G,et al. Cyclosporine before PCI in patients
with acute myocardial infarction[J]. New Engl J Med,2015,373(11):
1021-31.
[5] 赵莉,王晨霞,高智耀. 不同剂量瑞舒伐他汀对急性心肌梗死患者
心功能的影响[J]. 临床和实验医学杂志,2015,14(20):1698-700.
[6] 中华医学会心血管病学分会. 急性心肌梗死诊断和治疗指南[J].
中华心血管病杂志, 2001,16(12):710-25.
[7] 熊斌,冯文伟,林海云,等. 急诊 PCI 应用前列地尔对急性 ST 段
抬高型心肌梗死再灌注的影响[ J ] . 湖南师范大学学报医学
版,2015,12(3):79-81.
[8] Thiele H,Schuler G,Neumann FJ,et al. Intraaortic balloon
counterpulsation in acute myocardial infarction complicated by
cardiogenic shock: Design and rationale of the Intraaortic Balloon
Pump in Cardiogenic Shock II (IABP-SHOCK II) trial[J]. Am Heart
J,2015,169(4):938-45.
[9] Zamani P,Schwartz GG,Olsson AG,et al. Inflammatory biomarkers,
death, and recurrent nonfatal coronary events after an acute coronary
syndrome in the MIRACL study[J]. J Am Heart Assoc,2013,2(1):
e003103.
[10] 冯文伟,熊斌. 前列地尔对急性心肌梗死患者行急诊经皮冠状动
脉介入治疗术后心功能的影响研究[J]. 实用心脑肺血管病杂
志,2015,23(1):20-3.
[11] 解金红,陈玉善,罗明华,等. 大剂量阿托伐他汀对急性心肌梗死
患者行PCI术再灌注后ET、NO、slCAM-1及hs-CRP的影响[J].
疑难病杂志,2015,14(5):445-8.
[12] Hartmann M,Von BC,Mintz GS,et al. Relation between lipoprotein(a)
and fibrinogen and serial intravascular ultrasound plaque progression
in left main coronary arteries[J]. J Am Coll Cardiol,2006,48(3):446-52.
[13] 陈文,程芳洲. 瑞舒伐他汀与阿托伐他汀对急性心肌梗死患
者PCI治疗后血清炎症因子表达的影响[J]. 岭南心血管病杂
志,2013,19(4):417-20.
[14] 沈娜,杨增芯. 瑞舒伐他汀对行 PCI 术急性心肌梗死患者血清
cTNI、Cys-C、Hcy 及心肌酶、炎症因子水平的影响[J]. 海南医
学院学报,2016,22(21):2544-7.
[15] 张建标,马列婷. 血脂和糖化血红蛋白对2型糖尿病合并冠心病的
影响及早期诊断意义[J]. 陕西医学杂志,2014,43(11):1525.
  • 2008

  • 1

通讯地址:北京市东城区东四十条南门仓5号
电话: 237499284 邮编:100700
网址:www.ebcvm..org Email: ebcvm_cj@126.com

copyright © 《中国循证心血管医学杂志》编辑部
当您在使用本网站投稿遇到困难时,
请直接将稿件投送到编辑部邮箱ebcvm_cj@126.com